Healthtech Startups

Normunity develops biologic anti-cancer therapies that act at the interface of the immune system and tumors, targeting mechanisms tumors use to evade immune surveillance. The company builds its drug discovery pipeline through a partnership with the Lieping Chen lab at Yale School of Medicine, focusing on solid tumors.

6 investors

Nutrisense provides personalized metabolic monitoring and health guidance through continuous glucose monitoring and data analysis. The platform helps individuals understand their body's metabolic response to food and lifestyle choices to build sustainable health habits.

6 investors

Nym automates the medical coding process for US healthcare providers by using AI to interpret clinical language and power revenue cycle management. The company's autonomous coding engine processes millions of patient encounters annually across over 400 healthcare facilities.

6 investors

Olema is a clinical-stage biopharmaceutical company developing novel therapies for metastatic breast cancer and other endocrine-driven cancers, targeting nuclear receptors and mechanisms of acquired resistance. It focuses on improving treatment outcomes for patients living with breast cancer.

6 investors

Olio Labs develops drug combination therapies using machine learning to identify treatments that target multiple interacting proteins simultaneously, with initial candidates focused on obesity treatment. The company aims to create pharmaceutical solutions that achieve greater efficacy and lower side effect profiles than existing single-target medications.

6 investors

OM1 develops AI-powered analytics and data infrastructure for healthcare organizations to measure patient outcomes, predict health trajectories, and accelerate medical research using real-world clinical data. The platform serves healthcare systems, pharmaceutical companies, and research organizations seeking to close evidence gaps and improve clinical decision-making.

6 investors

OncoHealth develops software and services to help health plans, employers, and oncologists manage cancer care and reduce treatment complexity. The platform combines oncology management tools with nursing, mental health, nutrition, and navigation services for patients and health systems.

6 investors

OneImaging coordinates medical imaging appointments across the United States, directing patients to appropriate scan sites based on need and price while connecting patients, providers, and payers. It plans to add AI-based decision support, image sharing, and provider onboarding tools for its imaging network.

6 investors

Ophelia provides medication-assisted treatment for opioid addiction through a telemedicine platform, allowing patients to receive care without attending residential rehab. The service is designed for individuals struggling with opioid addiction who prefer privacy-respecting, home-based treatment options.

6 investors

Orbem uses AI-powered MRI technology to analyze biological materials and provide detailed insights to customers in agriculture and food production. The platform reveals internal characteristics of items like eggs and avocados to reduce waste and increase supply chain transparency.

6 investors

ORIC Pharmaceuticals is a clinical-stage oncology company developing therapies aimed at overcoming cancer treatment resistance, including innate, acquired, and bypass resistance. Its pipeline includes rinzimetostat (ORIC-944) in Phase 1b for prostate cancer and enozertinib (ORIC-114) in Phase 1b for non-small cell lung cancer with EGFR mutations.

6 investors

Oshi provides virtual gastrointestinal care delivered by gastroenterologists, dietitians, and gut-brain specialists to patients seeking treatment for GI conditions. The platform combines evidence-based dietary intervention and mental health support to help patients manage digestive health symptoms.

6 investors

Osso develops virtual reality training scenarios for nurses, nurse leaders and healthcare system administrators, offering self-guided learning, skill assessment, and collaborative training on one platform. Its 6 Domains of Excellence methodology organizes quality and accreditation standards into a framework for hospitals.

6 investors

Outbound AI builds conversational AI agents that automate phone-based administrative work in healthcare, particularly for medical billing and revenue cycle tasks. The platform serves physician practices, healthcare enterprises, and healthcare partners looking to reduce manual administrative labor and improve workforce productivity.

6 investors

Owkin develops AI Scientist, an autonomous AI system that uses biological large language models and multimodal patient data to accelerate drug discovery for pharmaceutical and biotech companies. The company aims to automate early-stage R&D and compress decades of discovery timelines into years.

6 investors

Pacagen develops allergen-neutralizing sprays using proprietary WhiskerBlock™ and EnviroBlock™ technologies that target pet and dust mite allergens at the molecular level. The company serves allergy sufferers seeking an alternative to traditional antihistamines and medications.

6 investors

Paradigm Health provides technology and services that integrate with healthcare provider organizations to improve the clinical trial process. It works with providers and sponsors to increase patient enrollment and expand patient access to clinical trials.

6 investors

Pencil Biosciences develops a fully synthetic, modular, non-CRISPR gene editing platform that edits DNA without causing a break or nick. The technology targets applications in therapeutics and cell line engineering.

6 investors

Perfuse Therapeutics develops novel ocular therapies for retinal and glaucoma diseases through drug delivery and formulation platforms. The company focuses on advancing therapeutic programs from preclinical development through clinical stages.

6 investors

Pharvaris develops investigational oral therapies for people living with bradykinin-mediated angioedema. It is a clinical-stage biopharmaceutical company focused on this rare disease area.

6 investors

Plenful is an AI platform that automates complex administrative workflows in pharmacy operations, designed for healthcare organizations and pharmacy teams. The company aims to reduce manual inefficiencies, errors, and delays in patient care delivery through intelligent automation built by former pharmacy operators and AI engineers.

6 investors

PMV Pharma is a precision oncology company developing therapies that selectively target mutant p53 to treat cancers whose tumors carry p53 gene mutations. Its lead program is rezatapopt, a reactivator of the p53 Y220C mutation in clinical trials.

6 investors

Pomelo provides maternity and neonatal care services, offered as a benefit to employees or members through employer and organizational partnerships. It focuses on improving outcomes in maternal and newborn health.

6 investors

Postera uses artificial intelligence and computational chemistry to accelerate drug discovery for pharmaceutical companies. The platform combines machine learning, medicinal chemistry, and software engineering to improve the drug development process.

6 investors